OptiNose, Inc.
- Raised $4.7 million (2024)
- 2 clinical trials
- Founded 2010
Life science companies
Explore 13,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
OtoNexus Medical Technologies, Inc.
- Raised $13 million (2024)
- Research grants: $2.3 million
- Founded 2010
Oyster Point Pharma, Inc.
- Raised $85 million (2019)
- 13 clinical trials
- Founded 2015
Polarityte, Inc.
- Raised $4 million (2022)
- 5 clinical trials, 1 active
Semnur Pharmaceuticals, Inc.
OTC: SMNR
- Raised $6 million (2013)
- 3 clinical trials, 1 active
- Founded 2013
TC BioPharm (Holdings) plc
- Raised $7.3 million (2022)
- 5 clinical trials, 1 active
Vedanta Biosciences, Inc.
- Raised $119 million (2024)
- 5 clinical trials, 1 active
Ventus Therapeutics U.S., Inc.
- Raised $70 million (2022)
- 2 clinical trials, 1 active
- Founded 2019
Viewpoint Molecular Targeting, Inc.
- Raised $14 million (2021)
- Research grants: $25 million
Anumana, Inc.
- Raised $32 million (2022)
- 2 clinical trials
- FDA-cleared or approved devices
- Founded 2020
Embolx, Inc.
- Raised $662 (2014)
- FDA-cleared or approved devices
- Research grants: $4.2 million
- Founded 2013
ROM Technologies, Inc.
- Raised $448 million (2026)
- 2 clinical trials, 1 active
- 1 FDA-registered device site
- Founded 2020
Sequon, Inc
- 1 clinical trial, 1 active
- 1 FDA-registered device site
- Research grants: $2.6 million
TMRW Life Sciences, Inc.
- Raised $38 million (2026)
- 2 clinical trials
- FDA-cleared or approved devices
- Founded 2018
Ulthera Inc
- Raised $11 million (2011)
- 51 clinical trials, 1 active
- Founded 2005
Vektor Medical, Inc.
- Raised $29 million (2024)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2017
Endotronix Inc
- Raised $69 million (2020)
- 6 clinical trials, 4 active
- FDA-cleared or approved devices
- Founded 2007
Intercept Pharmaceuticals, Inc.
- Raised $30 million (2012)
- 22 clinical trials
AgeneBio, Inc.
- Raised $500,076 (2016)
- 2 clinical trials
- Research grants: $6.5 million
- Founded 2008
Amprion, Inc.
- Raised $5.8 million (2024)
- Research grants: $19 million
Clementia Pharmaceuticals Inc.
- Raised $60 million (2015)
- 10 clinical trials
- Founded 2010
Dermira, Inc.
- Raised $1 million (2018)
- 17 clinical trials, 1 active
- Founded 2010
Evelo Biosciences, Inc.
- Raised $82 million (2018)
- 10 clinical trials
- Founded 2014
Galmed Pharmaceuticals Ltd.
Nasdaq: EOCN
- Raised $100,000 (2017)
- 10 clinical trials, 1 active
- Founded 2013
Infinity Pharmaceuticals, Inc.
- Raised $79 million (2012)
- 24 clinical trials
Intarcia Therapeutics, Inc
- Raised $198 million (2020)
- 21 clinical trials
Nevro Corp
- Raised $59 million (2011)
- 10 clinical trials, 3 active
- Founded 2006
Alpenglow Biosciences, Inc.
- Raised $3 million (2025)
- Research grants: $6.7 million
- Founded 2018
Amplyx Pharmaceuticals, Inc.
- Raised $91 million (2020)
- Research grants: $15 million
AtlasXomics Inc.
- Raised $3.9 million (2022)
- Research grants: $6.2 million
- Founded 2020
Avails Medical, Inc.
- Raised $6.4 million (2017)
- FDA-cleared or approved devices
- Research grants: $450,000
- Founded 2013
DTx Pharma, Inc.
- Raised $100 million (2021)
- Research grants: $3.1 million
- Founded 2017
Eargo, Inc.
- Raised $82 million (2020)
- FDA-cleared or approved devices
Enterra Medical, Inc.
- Raised $19 million (2022)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2021
Hyalex Orthopaedics, Inc.
- Raised $15 million (2024)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2016
Luminopia, Inc.
- Raised $16 million (2023)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2015
MediView XR, Inc.
- Raised $14 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Founded 2019
Mitotherapeutix, LLC
- Raised $3 million (2025)
- Research grants: $6 million
- Founded 2014
Nexgel, Inc.
Nasdaq: NXGL
- Raised $1.6 million (2021)
- FDA-cleared or approved devices
R3 Vascular Inc.
- Raised $72 million (2024)
- 3 clinical trials, 3 active
- 1 FDA-registered device site
- Founded 2019
Rejoni, Inc.
- Raised $26 million (2023)
- 3 clinical trials
- FDA-cleared or approved devices
- Founded 2020
Reprise Biomedical, Inc.
- Raised $1.4 million (2026)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2019
Sirnaomics, Inc.
- Raised $15 million (2020)
- 13 clinical trials, 2 active
- Research grants: $1.2 million
Vycor Medical Inc
OTC: VYCO
- Raised $618,607 (2017)
- FDA-cleared or approved devices
- Founded 2007
Accelerate Diagnostics, Inc
- Raised $4 million (2022)
- 4 clinical trials
Biophytis SA
- Raised $1.6 million (2026)
- 4 clinical trials, 1 active
CND Life Sciences, Inc.
- Raised $4.3 million (2026)
- Research grants: $19 million
- Founded 2017
Cognito Therapeutics Ltd.
- Raised $10 million (2024)
- 4 clinical trials, 2 active
eFFECTOR Therapeutics, Inc.
- Raised $20 million (2019)
- 9 clinical trials
- Founded 2012
Entasis Therapeutics Holdings Inc.
- Raised $25 million (2020)
- 10 clinical trials, 1 active
- Founded 2018
Published company profiles only; counts update daily. Data licences